La Terapia Di Supporto Nei Pazienti Con Carcinoma Del Colon-Retto

Boyle P. : Some recent developments in the epidemiology of colorectal cancer. In: Bleiberg H. , Rougier P. , Wilke H.J. : Management of colorectal cancer, pp. 19–34, Martin Dunitz, London, 1998.

Machover D. , Diaz-Rubio E. , de Gramont A. , Schilf A. , Gastiaburu J.J. , Brienza S. , Itz M. , Metzger G. , N'Daw D. , Vignoud J. , Abad A. , Francois E. , Gamelin E. , Marty M. , Sastre J. , Seitz J.F. , Ychou M. : Two consecutive studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann. Oncol., 7: 95–98, 1996.

Zalcberg J.R. , Cunningham D. , Van Cutsen E. , Francois E. , Schornagel J. , Adenis A. , Green M. , Iveson A. , Azab M. , Seymour I. : ZD1694: a novel thymidylate synthase inhibitor has substantial activity in the treatment of patients with advanced colorectal cancer Tomudex Colorectal Study Group. J. Clin. Oncol., 14: 716–721, 1996.

Gianni L. , Sessa C. , Capri G. , Grasselli G. , Spataro V. , Benadonna G. : Farmaci chemioterapici. In: Bonadonna G. , Robustelli G. Delia Cuna, Medicina oncologica, VI Ed, pp. 535–615, Masson, Milano, 1999.

Massidda B. : Irinotecan (CPT11) in metastatic colorectal cancer patients resistant to HX 5-FU. Tumori, 83: 8–9, 1997.

Bauer K.A. , Levine M. : Evaluation and management of the cancer patients with thrombosis. ASCO, 223, 1999.